Dr. Laura Niklason
@DrLauraNiklason
Followers
530
Following
136
Statuses
80
RT @humacyte: Humacyte provided a 2023 Q3 financial and corporate update on Thursday. Read the full recap here:
0
3
0
RT @humacyte: Our CEO, @DrLauraNiklason, is featured in this week’s @FoxNewsSunday highlighting how Humacyte’s revolutionary bioengineered…
0
9
0
RT @humacyte: We recently sat down with @thisisinsider to talk about the impact of our Human Acellular Vessel™ (HAV™) in #Ukraine and what…
0
6
0
RT @IN_publishing: “The completion of the target enrolment in @humacyte's Phase II/III #vascular #trauma trial is expected to enable BLA su…
0
10
0
RT @humacyte: We’re proud to share a new study published in @JVS_VascSci describing the scientific basis for the significantly lower rates…
0
11
0
RT @humacyte: Trial Update: We have completed enrollment in our Phase 2/3 vascular trauma trial that is expected to support the BLA filing…
0
6
0
Thrilled to see the enthusiasm and passion from Dr. Lane in this video discussing the HAV and its use in the @VASanDiego population. The entire team at @humacyte is grateful to the dedicated members of our clinical sites who have moved this study to enrollment completion!
Vascular surgeon Dr. John Lane of @UCSDMedSchool & @VASanDiego discusses the vast potential of Human Acellular Vessel (HAV) for people living with end-stage renal disease, calling it the “holy grail” of vascular research topics in the last twenty years.
4
1
7
It's an honor to lead a company full of extraordinary women at every level who come to work each day with the mission of revolutionizing medical care. Together, we can shape the future for women in science... Shoutout to the brilliant ladies of @humacyte! #InternationalWomensDay
3
2
11
Having founded @humacyte nearly 20 years ago w/ @blum_jl & Shannon Dahl, it's inspiring beyond words to continue seeing so many brilliant women working within the organization & driving our regen med products forward to change the lives of patients #IWD2023 #WomenInScience
As a female-founded company, Humacyte is proud to employ a 52% #female workforce full of creative, intelligent, forward-thinking women who come to work every day with a mission to change the world and patient care. #IWD2023 #BreakTheBias #InternationalWomensDay
1
2
22
Last month we hit a milestone: over 10 years of in-human use of the HAV. Now, we’re sharing long-term use data from a Phase 2 clinical trial. I encourage each of you to read the release and publication to learn more about the study!
A recent publication in @JVascSurg describes the long-term analysis of our HAV in a Phase 2 clinical trial evaluating the bioengineered vessel in patients with symptomatic PAD. Read more here:
3
4
35
RT @adardik: Just published in @JVS_VascSci: @DrLauraNiklason shows that the bioengineered human acellular vessel represents a durable opt…
0
9
0
Thanks to all who joined in this morning's @humacyte call! $HUMA
This morning’s $HUMA call call covered clinical, publication, and coroporate updates, as well as financial highlights for Q3 2022. To learn more about the information discussed, read the press release here:
2
1
12
Enjoyed presenting at @American_Heart with Dr. Alan Kypson this week. Exciting data from our pre-clinical #CABG work, and lots of enthusiasm from attendees at #AHA22 who realize the potential of the #HAV in the bypass field!
We presented six-month #HAV™ Coronary Artery Bypass Graft (CABG) Data at the @American_Heart Scientific Sessions meeting this week. Read more about our #AHA22 presentations here:
1
4
15
RT @humacyte: We're excited to be at @American_Heart #AHA22 here in #Chicago! Visit us at Booth 2918 to meet our team, get a first-hand loo…
0
5
0
Delighted to be included in the @Duke_Anesthesia alumni #BluePrint magazine! Check out the article for a glimpse into my career, catalysts behind the creation of @humacyte, and my time at #Duke.
📖Read the ALUMNI NOTES in our Duke Anesthesiology 2022 BluePrint magazine #DukeAnesBP, featuring a Q&A with Duke alumna Dr. Laura Niklason of @humacyte: 📖VIEW FULL ISSUE:
0
2
9
Thank you @trasmussen_md for sharing your experiences utilizing the #HAV with this audience of international #surgeons at @ICMM_org!
@trasmussen_md's @ICMM_org presentation highlighted clinical progress of the HAV, his experience utilizing the #HAV to treat patients, & the potential of the investigational product to overcome current limitations in the care of vascular injury. Read more:
0
2
9
@BillGates and @SpaceX are each pioneers in their respective fields. In my eyes, the incredible team at @humacyte is no different - we are working hard every single day to turn science fiction into science fact.
What a compliment to be compared to @BillGates & @SpaceX! Alike the work bringing computers to the masses or making space travel accessible for all, $HUMA's focused on staying at the forefront of regen med & delivering greater options for patient care around the world.
1
2
7
RT @FAERanesthesia: Learn more about the work of @DrLauraNiklason, 1995 #FAERgrantee and CEO & Founder of @humacyt…
0
4
0